Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
about
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignanciesAngiogenesis in male breast cancerALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migrationEndoglin in liver fibrogenesis: Bridging basic science and clinical practiceRole of transforming growth factor beta in cancer.Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressureHGF-transgenic MSCs can improve the effects of tissue self-repair in a rabbit model of traumatic osteonecrosis of the femoral head.Identify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chipCD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patientsResearch on potential biomarkers in hereditary hemorrhagic telangiectasia.Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.High-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathyPlasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcomaThe relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer.A list of candidate cancer biomarkers for targeted proteomics.ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumoursBoth high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinomaControl of the adaptive immune response by tumor vasculature.The physiological role of endoglin in the cardiovascular system.Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.TGF-β and its coreceptors in cancerogenesis: an overview.Endoglin for tumor imaging and targeted cancer therapy.Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.The expression and characterization of endoglin in uterine leiomyosarcoma.In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours.Overexpression of endoglin (CD105) is associated with recurrence in radically resected gastric cancer.Soluble endoglin antagonizes Met signaling in spindle carcinoma cells.Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.Endoglin - a marker of vascular endothelial cell proliferation in cancer.Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters.Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.Soluble Endoglin (CD105) Serum Level as a Potential Marker in the Management of Head and Neck Paragangliomas.Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia
P2860
Q24291272-190B0BDE-83F8-42B6-B401-AB2FDD3D0409Q24803467-96A90852-FEDB-4224-A96A-2205E758D997Q33705264-5156072F-D752-4B78-9F1B-CB6C7C0D7A34Q33728841-C839C547-3574-4EBB-B613-F534ABE80057Q34136011-49C55E28-398F-4F2F-B88A-2A19F9D4BE80Q34136521-1B118DE7-3522-48B1-9F50-2F4B6CCDAC3AQ34143652-B74B3194-CBAC-41A2-A10D-C0B7E20C68A6Q34281939-8EF96975-5A33-4824-BE10-5102FE903F13Q35010418-89094873-5136-431A-B91C-0393A8076343Q35214342-D6E001B9-E134-4111-BFA2-E56F3EE09B34Q35233736-DD69C48D-01A2-4E99-924F-F2B235B25606Q35628653-51EE572C-EF61-4941-9FD1-44C68A4B010CQ36340353-A2FBB88F-1B29-48CD-96A7-79E487BE2957Q36557592-52582CB5-0529-4B87-B3F1-2EC40E63841EQ36612601-3A037684-8772-4443-8CD9-63A8110D2C1AQ37277962-47BC5847-99AA-486B-B1B3-927B41787CDBQ37295765-F2259F06-7A34-4531-949E-34AF02A5C383Q37340349-5BBCADC3-B9F4-4D8A-B024-229DCCE76896Q37681761-C882A02F-B8D3-4420-BD97-B7DF5077D827Q37683575-F36EF627-4F98-4F3B-9CC8-5AC9E20124C7Q37775427-97D8E828-B84F-4CB8-BFA7-3278D8CAAFCBQ37954333-CE3B0F3D-6333-48BE-9870-3836E5F3BE3EQ37959017-4C6FC45A-E878-4B83-BF11-B8377609F90CQ38074721-69B406B2-D578-409D-9DA4-62659468885FQ38588911-8EA0170C-C0AA-42D4-96B1-429D56619DFDQ38838413-6276CE59-5A2E-405E-A70F-2048D44597F4Q39016514-71631357-3128-4FA2-90A3-D2FD2DEE668CQ39196836-89DE1C7C-BB0E-4F4B-86BE-E93086422A33Q39257411-D27B263C-3241-4FB6-8876-F50D4650EFE0Q41970114-74BDF2E5-91C2-4FA1-97E3-93E5A5CFEB5BQ42470252-404CDB57-8C4D-4428-95EC-C3FF805CAB38Q42483948-EA1803B5-5F81-4214-AD53-4F440E9C1278Q43121223-198E77F4-E7A1-4CF6-A3AD-41AC0E493860Q43864995-F9009428-31E3-4489-8505-C8B65642B3E2Q45878165-47ADE31B-7951-4DC3-AC96-14A7906841EDQ46733681-CEDBC381-2095-4AA8-8241-299BD5B354D5Q47869338-A5D0C144-9257-4689-9D8D-16210C18B0DFQ58703191-D90EBBE4-D366-4A39-9E1C-C12837C458B6
P2860
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
description
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im März 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 20 March 2000)
@en
vedecký článok (publikovaný 2000/03/20)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/03/20)
@nl
наукова стаття, опублікована в березні 2000
@uk
مقالة علمية (نشرت في 20-3-2000)
@ar
name
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@ast
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@en
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@nl
type
label
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@ast
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@en
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@nl
prefLabel
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@ast
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@en
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@nl
P2093
P2860
P1476
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
@en
P2093
P B Wilson
P2860
P356
10.1002/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M
P407
P577
2000-03-20T00:00:00Z